Anne Bertrand1, Adrien Pasquier1,
Alexandra Petiet1,2, Christopher Wiggins2, Sebastien
Meriaux2, Audrey Kraska1, Olene Dorieux1,3,
Nelly Joseph-Mathurin1, Philippe Hantraye1, Fabienne
Aujard3, Nadine Mestre-Frances4, Marc Dhenain1,2
1CEA, I2BM, MIRCen-URA2210, Fontenay
aux Roses, France; 2CEA, I2BM, Neurospin, Gif-sur-Yvette, France; 3UMR
CNRS/MNHN 7179, Brunoy, France; 4INSERM U710- EPHE- Universit
Montpellier 2, Montpellier, France
Amyloid
deposits are one of the characteristic lesions of Alzheimer's disease. Their
sizes range from 50 m to 200 m. These lesions can be detected in transgenic
mouse model of Alzheimer's disease by MRI, however, amyloid deposits in mice
are very different than those occurring spontaneously in aged primates or
humans with Alzheimer's disease. Here, we show that a protocol based on the
staining of amyloid plaques with a non targeted Gadolinium contrast agent
allows to detect spontaneously occurring amyloid plaques in aged mouse lemur
Primates.